Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
暂无分享，去创建一个
N. LeBoeuf | M. Asgari | V. Naranbhai | K. Reynolds | S. Kwatra | V. Pahalyants | N. Raval | M. Carrington | L. Zubiri | T. Le | Y. Semenov | A. Gusev | P. Ugwu-Dike | K. Tang | J. Seo | Bruce C Tiu | Mary Carrington